Ricevi le ultime notizie sulle azioni RAPT Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di RAPT

Ultime notizie per

RAPT THERAPEUTICS INC

RAPT Therapeutics

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

RAPT Therapeutics Inc

News

Management

Press Releases

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Earnings

RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

RAPT Therapeutics to Participate in Upcoming Investor Conferences

Health Care

RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development

RAPT Therapeutics Reports First Quarter 2025 Financial Results

RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split

RAPT Therapeutics Names Two Industry Veterans to its Board of Directors

RAPT Therapeutics Reports Second Quarter 2025 Financial Results

CTNM

RAPT

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

C4 Therapeutics

Caribou Biosciences

Cardiff Oncology

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals

Elicio Therapeutics

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

Eupraxia Pharmaceuticals Inc. - Common Stock

Eupraxia Pharmaceuticals

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

Immuneering Corporation - Class A Common Stock

Immuneering

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Korro Bio

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Seres Therapeutics

MEI Pharma

Monopar Therapeutics

Nkarta

Nuvectis Pharma

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

Instil Bio

Tenaya Therapeutics

Tevogen Bio Holdings

Voyager Therapeutics, Inc. - Common Stock

Comments

RAPT Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO